Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $53.2900 (0.6%) ($53.2900 - $53.2900) on Mon. Nov. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 69 | Latest Price | $53.2900(0.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 6.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(33%) IWO(32%) IWM(31%) IWN(29%) | Factors Impacting HALO price | HALO will decline at least -1.135% in a week (0% probabilities). VIXM(-11%) XBI(-7%) VXX(-6%) IGOV(-5%) GLD(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $53.22(0.13%) | 10 Day Moving Average | $52.38(1.74%) | 20 Day Moving Average | $49.93(6.73%) | To recent high | -1.4% | To recent low | 38.4% | Market Cap | $7.283b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |